BMPR2 and pulmonary arterial hypertension: For example, Sal A ameliorated pulmonary remodeling in monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) rats by activating the BMPRII-Smad pathway and inhibiting apoptosis (Chen Y. C. et al., 2016).